Developer of biosimilar theraputics
Work to reconsider current CMS position on the structure of the Medicare J-Code for biosimilar medications. Work to reconsider current CMS position on the structure of the Medicare J-Code for biosimilar medications. Work to reconsider current CMS position on the structure of the Medicare J-Code for biosimilar medications.
MMM - Medicare/Medicaid HCR - Health Issues PHA - Pharmacy
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
NATHANSON+HAUCK
601 13th Street NW, Suite 290 North, Washington, DC, 20005, US
MELANIE JAN NATHANSON MEGAN HAUCK MARSHALL MELANIE JAN NATHANSON MEGAN HAUCK MARSHALL MELANIE JAN NATHANSON MEGAN HAUCK MARSHALL